Skip to main content
Top
Published in: BMC Women's Health 1/2015

Open Access 01-12-2015 | Research article

Cytological evaluation of breast lesions in symptomatic patients presenting to Kenyatta National Hospital, Kenya: a retrospective study

Authors: Ken Munene Nkonge, Emily Adhiambo Rogena, Edwin Owino Walong, Dennis Karani Nkonge

Published in: BMC Women's Health | Issue 1/2015

Login to get access

Abstract

Background

Palpable breast lump, breast pain, and nipple discharge are common symptoms of breast disease. Breast cytology (fine-needle aspiration, nipple discharge smear, and touch preparation) accurately identifies benign, atypical, and malignant pathological changes in breast specimens. This study aims to determine the types of breast lesions diagnosed by breast cytology and assess the clinical adequacy of narrative reporting of breast cytology results.

Methods

Medical records of 390 patients presenting to breast or general surgery clinics in Kenyatta National Hospital, Nairobi, Kenya, between January 2010 and March 2014 were evaluated retrospectively.

Results

Of the 390 diagnosed breast lesions, 89.7 % (n = 350) occurred in females, while 10.3 % (n = 40) occurred in males, giving rise to a female-to-male ratio of 8.8:1. Neoplastic breast lesions (n = 296) comprised 75.9 %, while non-neoplastic breast lesions (n = 94) comprised 24.1 % of all diagnosed breast lesions. The neoplastic lesions were classified as 72.3 % (n = 214) benign and 27.7 % (n = 82) malignant, resulting in a benign-to-malignant ratio of 2.6:1. Fibroadenoma (n = 136) and gynecomastia (n = 33) were the most frequently diagnosed breast lesions for women and men, respectively.

Conclusions

Breast cytology effectively diagnosed neoplastic and non-neoplastic breast lesions. Neoplastic breast lesions occurred more frequently in women whereas non-neoplastic lesions occurred more frequently in men. To address the limitations associated with narrative reporting of breast cytology results, a synoptic reporting format incorporating the United Kingdom’s National Health Service Breast Screening Programme’s diagnostic categories (C1 to C5) is recommended for adoption by this hospital.
Literature
1.
go back to reference Barry M. Nipple discharge. In: Walker K, Hall D, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. Boston: Butterworths; 1990. p. 820–1. Barry M. Nipple discharge. In: Walker K, Hall D, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. 3rd ed. Boston: Butterworths; 1990. p. 820–1.
2.
go back to reference Salzman B, Fleegle S, Tully AS. Common breast problems. Am Fam Physician. 2012;86:343–9.PubMed Salzman B, Fleegle S, Tully AS. Common breast problems. Am Fam Physician. 2012;86:343–9.PubMed
3.
go back to reference Ngotho J, Githaiga J, Kaisha W. Palpable discrete breast masses in young women: two of the components of the modified triple test may be adequate. S Afr J Surg. 2013;51:58–60.CrossRefPubMed Ngotho J, Githaiga J, Kaisha W. Palpable discrete breast masses in young women: two of the components of the modified triple test may be adequate. S Afr J Surg. 2013;51:58–60.CrossRefPubMed
4.
go back to reference Morris A, Pommier RF, Schmidt WA, Shih RL, Alexander PW, Vetto JT. Accurate evaluation of palpable breast masses by the triple test score. Arch Surg. 1998;133:930–4.CrossRefPubMed Morris A, Pommier RF, Schmidt WA, Shih RL, Alexander PW, Vetto JT. Accurate evaluation of palpable breast masses by the triple test score. Arch Surg. 1998;133:930–4.CrossRefPubMed
5.
go back to reference Muchiri LW, Penner DW, Adwok J, Rana FS. Role of fine-needle aspiration biopsy in the diagnosis of breast lumps at the Kenyatta National Hospital. East Afr Med J. 1993;70:31–3.PubMed Muchiri LW, Penner DW, Adwok J, Rana FS. Role of fine-needle aspiration biopsy in the diagnosis of breast lumps at the Kenyatta National Hospital. East Afr Med J. 1993;70:31–3.PubMed
6.
go back to reference Edmund DM, Naaeder SB, Tettey Y, Gyasi RK. Breast cancer in Ghanaian women: what has changed? Am J Clin Pathol. 2013;140:97–102.CrossRefPubMed Edmund DM, Naaeder SB, Tettey Y, Gyasi RK. Breast cancer in Ghanaian women: what has changed? Am J Clin Pathol. 2013;140:97–102.CrossRefPubMed
7.
go back to reference Okoth C, Galukande M, Jombwe J, Wamala D. Benign proliferative breast diseases among female patients at a sub-saharan Africa tertiary hospital: a cross sectional study. BMC Surg. 2013;13:9.CrossRefPubMedPubMedCentral Okoth C, Galukande M, Jombwe J, Wamala D. Benign proliferative breast diseases among female patients at a sub-saharan Africa tertiary hospital: a cross sectional study. BMC Surg. 2013;13:9.CrossRefPubMedPubMedCentral
8.
go back to reference Bjerregaard B, Kung’u A. Benign breast lesions in Kenya: a histological study. East Afr Med J. 1992;69:231–5.PubMed Bjerregaard B, Kung’u A. Benign breast lesions in Kenya: a histological study. East Afr Med J. 1992;69:231–5.PubMed
9.
go back to reference Otieno ES, Kimende SK, Micheni JN. The pattern of breast diseases at Kenyatta National Hospital. Annals African Surgery. 2008;2:97–101. Otieno ES, Kimende SK, Micheni JN. The pattern of breast diseases at Kenyatta National Hospital. Annals African Surgery. 2008;2:97–101.
10.
go back to reference Otieno ES, Micheni JN, Kimende SK, Mutai KK. Delayed presentation of breast cancer patients. East Afr Med J. 2010;87:147–50.PubMed Otieno ES, Micheni JN, Kimende SK, Mutai KK. Delayed presentation of breast cancer patients. East Afr Med J. 2010;87:147–50.PubMed
11.
go back to reference Abati A, Simsir A. Breast fine needle aspiration biopsy: prevailing recommendations and contemporary practices. Clin Lab Med. 2005;25:631–54.CrossRefPubMed Abati A, Simsir A. Breast fine needle aspiration biopsy: prevailing recommendations and contemporary practices. Clin Lab Med. 2005;25:631–54.CrossRefPubMed
12.
go back to reference National Cancer Institute Fine-Needle Aspiration of Breast Workshop Subcommittees. The uniform approach to breast fine-needle aspiration biopsy. Diagn Cytopathol 1997, 16: 295–311.CrossRef National Cancer Institute Fine-Needle Aspiration of Breast Workshop Subcommittees. The uniform approach to breast fine-needle aspiration biopsy. Diagn Cytopathol 1997, 16: 295–311.CrossRef
13.
go back to reference Cytology Subgroup of the National Coordinating Committee for Breast Cancer Screening Pathology. Guidelines for cytology procedures and reporting in breast cancer screening. Sheffield: NHS Cancer Screening Programme; 2001. Publication No 50. Cytology Subgroup of the National Coordinating Committee for Breast Cancer Screening Pathology. Guidelines for cytology procedures and reporting in breast cancer screening. Sheffield: NHS Cancer Screening Programme; 2001. Publication No 50.
14.
go back to reference Kocjan G, Bourgain C, Fassina A, Hagmar B, Herbert A, Kapila K, et al. The role of breast FNAC in diagnosis and clinical management: a survey of current practice. Cytopathology. 2008;19:271–8.CrossRefPubMed Kocjan G, Bourgain C, Fassina A, Hagmar B, Herbert A, Kapila K, et al. The role of breast FNAC in diagnosis and clinical management: a survey of current practice. Cytopathology. 2008;19:271–8.CrossRefPubMed
15.
go back to reference Wai CJ, Al-Mubarak G, Homer MJ, Goldkamp A, Samenfeld-Specht M, Lee Y, et al. A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy. Ann Surg Oncol. 2013;20:850–5.CrossRefPubMed Wai CJ, Al-Mubarak G, Homer MJ, Goldkamp A, Samenfeld-Specht M, Lee Y, et al. A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy. Ann Surg Oncol. 2013;20:850–5.CrossRefPubMed
16.
go back to reference Panjvani SI, Parikh BJ, Parikh SB, Chaudhari BR, Patel KK, Gupta GS, et al. Utility of fine needle aspiration cytology in the evaluation of breast lesions. J Clin Diagn Res. 2013;7:2777–9.PubMedPubMedCentral Panjvani SI, Parikh BJ, Parikh SB, Chaudhari BR, Patel KK, Gupta GS, et al. Utility of fine needle aspiration cytology in the evaluation of breast lesions. J Clin Diagn Res. 2013;7:2777–9.PubMedPubMedCentral
17.
18.
go back to reference Walker S, Hyde C, Hamilton W. Risk of breast cancer in symptomatic women in primary care: a case–control study using electronic records. Br J Gen Pract. 2014;64:e788–93.CrossRefPubMedPubMedCentral Walker S, Hyde C, Hamilton W. Risk of breast cancer in symptomatic women in primary care: a case–control study using electronic records. Br J Gen Pract. 2014;64:e788–93.CrossRefPubMedPubMedCentral
19.
go back to reference Montroni I, Santini D, Zucchini G, Fiacchi M, Zanotti S, Ugolini G, et al. Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision. Breast Cancer Res Treat. 2010;123:895–900.CrossRefPubMed Montroni I, Santini D, Zucchini G, Fiacchi M, Zanotti S, Ugolini G, et al. Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision. Breast Cancer Res Treat. 2010;123:895–900.CrossRefPubMed
20.
go back to reference Gupta RK, Gaskell D, Dowle CS, Simpson JS, King BR, Naran S, et al. The role of nipple discharge cytology in the diagnosis of breast disease: a study of 1948 nipple discharge smears from 1530 patients. Cytopathology. 2004;15:326–30.CrossRefPubMed Gupta RK, Gaskell D, Dowle CS, Simpson JS, King BR, Naran S, et al. The role of nipple discharge cytology in the diagnosis of breast disease: a study of 1948 nipple discharge smears from 1530 patients. Cytopathology. 2004;15:326–30.CrossRefPubMed
21.
go back to reference Lang JE, Kuerer HM. Breast ductal secretions: clinical features, potential uses, and possible applications. Cancer Control. 2007;14:350–9.PubMed Lang JE, Kuerer HM. Breast ductal secretions: clinical features, potential uses, and possible applications. Cancer Control. 2007;14:350–9.PubMed
22.
go back to reference Dolan RT, Butler JS, Kell MR, Gorey TF, Stokes MA. Nipple discharge and the efficacy of duct cytology in evaluating breast cancer risk. Surgeon. 2010;8:252–8.CrossRefPubMed Dolan RT, Butler JS, Kell MR, Gorey TF, Stokes MA. Nipple discharge and the efficacy of duct cytology in evaluating breast cancer risk. Surgeon. 2010;8:252–8.CrossRefPubMed
23.
go back to reference Casati B, Haugland HK, Barstad GM, Bjugn R. Factors affecting the implementation and use of electronic templates for histopathology cancer reporting. Pathology. 2014;46:165–8.CrossRefPubMedPubMedCentral Casati B, Haugland HK, Barstad GM, Bjugn R. Factors affecting the implementation and use of electronic templates for histopathology cancer reporting. Pathology. 2014;46:165–8.CrossRefPubMedPubMedCentral
24.
go back to reference Tsuchiya S, Akiyama F, Moriya T, Tsuda H, Umemura S, Katayama Y, et al. A new reporting form for breast cytology. Breast Cancer. 2009;16:202–6.CrossRefPubMed Tsuchiya S, Akiyama F, Moriya T, Tsuda H, Umemura S, Katayama Y, et al. A new reporting form for breast cytology. Breast Cancer. 2009;16:202–6.CrossRefPubMed
25.
go back to reference Srigley JR, McGowan T, Maclean A, Raby M, Ross J, Kramer S, et al. Standardized synoptic cancer pathology reporting: a population-based approach. J Surg Oncol. 2009;99:517–24.CrossRefPubMed Srigley JR, McGowan T, Maclean A, Raby M, Ross J, Kramer S, et al. Standardized synoptic cancer pathology reporting: a population-based approach. J Surg Oncol. 2009;99:517–24.CrossRefPubMed
Metadata
Title
Cytological evaluation of breast lesions in symptomatic patients presenting to Kenyatta National Hospital, Kenya: a retrospective study
Authors
Ken Munene Nkonge
Emily Adhiambo Rogena
Edwin Owino Walong
Dennis Karani Nkonge
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2015
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-015-0278-y

Other articles of this Issue 1/2015

BMC Women's Health 1/2015 Go to the issue